Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Catalytic enantioselective Minisci-type addition to heteroarenes.

Proctor RSJ, Davis HJ, Phipps RJ.

Science. 2018 Apr 27;360(6387):419-422. doi: 10.1126/science.aar6376. Epub 2018 Apr 5.

PMID:
29622723
2.

meta-Selective C-H Borylation of Benzylamine-, Phenethylamine-, and Phenylpropylamine-Derived Amides Enabled by a Single Anionic Ligand.

Davis HJ, Genov GR, Phipps RJ.

Angew Chem Int Ed Engl. 2017 Oct 16;56(43):13351-13355. doi: 10.1002/anie.201708967. Epub 2017 Sep 19.

3.

Harnessing non-covalent interactions to exert control over regioselectivity and site-selectivity in catalytic reactions.

Davis HJ, Phipps RJ.

Chem Sci. 2017 Feb 1;8(2):864-877. doi: 10.1039/c6sc04157d. Epub 2016 Oct 5.

4.

Corrigendum: Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.

Kavanagh ME, Gray JL, Gilbert SH, Coyne AG, McLean KJ, Davis HJ, Munro AW, Abell C.

ChemMedChem. 2017 Jan 20;12(2):194-195. doi: 10.1002/cmdc.201600619. Epub 2016 Dec 19. No abstract available.

PMID:
28112499
5.

Ion Pair-Directed Regiocontrol in Transition-Metal Catalysis: A Meta-Selective C-H Borylation of Aromatic Quaternary Ammonium Salts.

Davis HJ, Mihai MT, Phipps RJ.

J Am Chem Soc. 2016 Oct 5;138(39):12759-12762. Epub 2016 Sep 21.

6.

Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.

Kavanagh ME, Gray JL, Gilbert SH, Coyne AG, McLean KJ, Davis HJ, Munro AW, Abell C.

ChemMedChem. 2016 Sep 6;11(17):1924-35. doi: 10.1002/cmdc.201600248. Epub 2016 Jul 19. Erratum in: ChemMedChem. 2017 Jan 20;12 (2):194-195.

7.

Spirooxindoles as novel 3D-fragment scaffolds: Synthesis and screening against CYP121 from M. tuberculosis.

Davis HJ, Kavanagh ME, Balan T, Abell C, Coyne AG.

Bioorg Med Chem Lett. 2016 Aug 1;26(15):3735-40. doi: 10.1016/j.bmcl.2016.05.073. Epub 2016 May 26.

PMID:
27287372
8.

A survey of UK dental health professionals using a medicines information service: what questions do they ask and do they get useful answers?

McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ, Randall CJ.

Br Dent J. 2011 Jul 8;211(1):17-21. doi: 10.1038/sj.bdj.2011.522.

PMID:
21738182
9.

Utility and value of a medicines information service provided by pharmacists: a survey of health professionals.

McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ.

Int J Pharm Pract. 2010 Dec;18(6):353-61. doi: 10.1111/j.2042-7174.2010.00068.x.

PMID:
21054596
10.

Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase gene.

Ehrenborg E, Clee SM, Pimstone SN, Reymer PW, Benlian P, Hoogendijk CF, Davis HJ, Bissada N, Miao L, Gagné SE, Greenberg LJ, Henry R, Henderson H, Ordovas JM, Schaefer EJ, Kastelein JJ, Kotze MJ, Hayden MR.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2672-8.

PMID:
9409241
11.

Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling.

Kotze MJ, Davis HJ, Bissbort S, Langenhoven E, Brusnicky J, Oosthuizen CJ.

Clin Genet. 1993 Jun;43(6):295-9.

PMID:
8370148
12.

[Genes and deviant behavior].

Gericke GS, Bissbort S, Davis HJ.

S Afr Med J. 1992 Apr 4;81(7):342-4. Afrikaans. No abstract available.

PMID:
1561551
13.

Job strain and satisfaction among unit managers.

Blalack RA, Davis HJ.

Hosp Top. 1977 Jan-Feb;55(1):30-5. No abstract available.

PMID:
838502
14.

Role clarity and other emotional reaction variables among Australian charge nurses.

Davis HJ, Popp GE.

Aust Nurses J. 1976 Jun;5(12):31-4. No abstract available.

PMID:
1048902
15.

Determination of the optimum dose of subcutaneous salbutamol in asthmatic patients.

Coady TJ, Stewart CJ, Davis HJ.

Br J Clin Pharmacol. 1976 Apr;3(2):239-42.

16.

Need satisfaction and the unit manager.

Davis HJ, Blalack RO.

Hosp Top. 1976 Jan-Feb;54(1):31-4. No abstract available.

PMID:
1254304
17.

Consideration of the relationship between the compliance of some intrauterine contraceptive devices and the expulsion rates (first).

Lesinski J, Davis HJ, Kummell JG.

J Reprod Med. 1973 Nov;11(5):213-4. No abstract available.

PMID:
4768150
18.

Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.

Aurelian L, Schumann B, Marcus RL, Davis HJ.

Science. 1973 Jul 13;181(4095):161-4.

PMID:
4711734
19.

Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma.

Aurelian L, Davis HJ, Julian CG.

Am J Epidemiol. 1973 Jul;98(1):1-9. No abstract available.

PMID:
4131112
20.

Cytopathology, histopathology, and colposcopy in the management of cervical neoplasia.

Thompson BH, Woodruff JD, Davis HJ, Julian CG, Silva FG 2nd.

Am J Obstet Gynecol. 1972 Oct 1;114(3):329-38. No abstract available.

PMID:
4564843
21.

Intrauterine contraceptive devices: present status and future prospects.

Davis HJ.

Am J Obstet Gynecol. 1972 Sep 1;114(1):134-51. Review. No abstract available.

PMID:
4564736
22.

Perfluoropolyether--a vacuum pump fluid resistant to electron induced polymerization.

Holland L, Laurenson L, Baker PN, Davis HJ.

Nature. 1972 Jul 7;238(5358):36-7. No abstract available.

PMID:
12635267
23.

HSV-2 antigens absent from biopsied cervical tumor cells: a model consistent with latency.

Aurelian L, Strandberg JD, Davis HJ.

Proc Soc Exp Biol Med. 1972 Jun;140(2):404-8. No abstract available.

PMID:
4556658
24.

Opportunities and procedures for the early diagnosis of carcinoma of the cervix.

Jones HW Jr, Davis HJ, Frost JK.

Md State Med J. 1972 Mar;21(3):54-8. No abstract available.

PMID:
5010908
25.

The biopsy-cucumber unit. A method to improve tissue orientation.

Swan RW, Davis HJ.

Obstet Gynecol. 1970 Nov;36(5):803-5. No abstract available.

PMID:
5474010
26.

The evolution of chromosomal aneuploidy in cervical atypia, carcinoma in situ and invasive carcinoma of the uterine cervix.

Jones HW Jr, Woodruff JD, Davis HJ, Katayama KP, Salimi R, Park IJ, Tseng PY, Preston E.

Johns Hopkins Med J. 1970 Sep;127(3):125-35. No abstract available.

PMID:
5472456
27.

Mechanism of action of intrauterine contraceptives in women.

Davis HJ, Lesinski J.

Obstet Gynecol. 1970 Sep;36(3):350-8. No abstract available.

PMID:
5451131
28.

Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.

Aurelian L, Royston I, Davis HJ.

J Natl Cancer Inst. 1970 Sep;45(3):455-64. No abstract available.

PMID:
4331639
29.

Genital herpes virus findings in relation to cervical neoplasia.

Royston I, Aurelian L, Davis HJ.

J Reprod Med. 1970 Apr;4(4):9-13. No abstract available.

PMID:
4328889
30.

The shield intrauterine device. A superior modern contraceptive.

Davis HJ.

Am J Obstet Gynecol. 1970 Feb 1;106(3):455-6. No abstract available.

PMID:
5410882
31.

Cervical cancer control with irrigation smears.

Davis HJ, Jones HW Jr.

Obstet Gynecol Surv. 1969 Jul;24(7 Pt 2):927-35. No abstract available.

PMID:
5212438
32.
33.

Correlated investigative technics of multiple anaplasias in the lower genital canal.

Woodruff JD, Davis HJ, Jones HJ Jr, Recio RG, Salimi R, Park IJ.

Obstet Gynecol. 1969 May;33(5):609-16. No abstract available.

PMID:
5778440
34.

Vulvovaginitis in the premenarcheal child.

Heller RH, Joseph JM, Davis HJ.

J Pediatr. 1969 Mar;74(3):370-7. No abstract available.

PMID:
4974526
35.

The value of the assay of chromosomes in the diagnosis of cervical neoplasia.

Jones HW Jr, Davis HJ, Frost JK, Park IJ, Salimi R, Tseng PY, Woodruff JD.

Am J Obstet Gynecol. 1968 Nov 1;102(5):624-41. No abstract available.

PMID:
5684540
36.

Cell volume profiles of irrigation smears for automated uterine cancer screening.

Davis HJ, Stafl A.

Obstet Gynecol. 1968 Aug;32(2):145-52. No abstract available.

PMID:
5754578
37.

Gas chromatographic determination of benzo(a)pyrene in cigarette smoke.

Davis HJ.

Anal Chem. 1968 Aug;40(10):1583-5. No abstract available.

PMID:
5743454
38.

Chromosomes of cervical atypia, carcinoma in situ, and epidermoid carcinoma of the cervix.

Jones HW Jr, Katayama KP, Stafl A, Davis HJ.

Obstet Gynecol. 1967 Dec;30(6):790-805. No abstract available.

PMID:
6061828
39.

Population screening for cancer of the cervix with irrigation smears.

Davis HJ, Jones HW Jr.

Am J Obstet Gynecol. 1966 Nov 1;96(5):605-18. No abstract available.

PMID:
5921421
40.

Relation of various epidemiologic factors to cervical cancer as determined by a screening program.

Naguib SM, Lundin FE Jr, Davis HJ.

Obstet Gynecol. 1966 Oct;28(4):451-9.

PMID:
5925030
41.

Nuclear protrusions and giant chromosome anomalies in cervical neoplasia.

Uyeda CK, Davis HJ, Jones HW Jr.

Acta Cytol. 1966 Sep-Oct;10(5):331-4. No abstract available.

PMID:
5230226
42.

Status of intrauterine devices in clinical practice.

Davis HJ.

Cmd. 1966 Jun;33:873-9.

PMID:
12255124
43.

Epidemiologic study of trichomoniasis in normal women.

Naguib SM, Comstock GW, Davis HJ.

Obstet Gynecol. 1966 May;27(5):607-16.

PMID:
5937665
44.

Effect of intrauterine contraceptive devices on the endometrium.

Israel R, Davis HJ.

JAMA. 1966 Feb 28;195(9):764-8. No abstract available.

PMID:
5951881
45.

Diagnostic procedures of cervical lesions.

Scott RB, Davis HJ.

Am J Obstet Gynecol. 1965 Dec 1;93(7):1048-51. No abstract available.

PMID:
5843408
46.

"PROKTOLOGICHESKAYA KLINIKA": THE U.S.S.R. COMBATS CANCER OF THE COLON AND RECTUM.

DAVIS HJ.

CA Cancer J Clin. 1963 Jul-Aug;13:160-2. No abstract available.

47.

HONORING THE LEGACY OF "PAP".

DAVIS HJ.

CA Cancer J Clin. 1963 Jul-Aug;13:158-9. No abstract available.

48.

The irrigation smear. A cytologic method for mass population screening by mail.

DAVIS HJ.

Am J Obstet Gynecol. 1962 Oct 15;84:1017-23. No abstract available.

PMID:
14025474
49.

The irrigation smear: accuracy in detection of cervical cancer.

DAVIS HJ.

Acta Cytol. 1962 Sep-Oct;6:459-67. No abstract available.

PMID:
13883910
50.

Detection of preinvasive cancer by the irrigation smear technic.

DAVIS HJ, KURZ L.

Dan Med Bull. 1962 Aug;9:121-6. No abstract available.

PMID:
13883909

Supplemental Content

Loading ...
Support Center